comparemela.com

Latest Breaking News On - Although khiron - Page 1 : comparemela.com

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis.

United statesUnited kingdomFranziska katterbachKhiron europeAlvaro torresHelen bellwoodCompany third quarterRegulation services providerKhiron life sciences corpLife sciencesLatin americaConference callThird quarterKhiron chief executive officerKhiron chief financial officerChief executive officer

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMXC), the global leader in medical cannabis.

United statesUnited kingdomFranziska katterbachKhiron europeAlvaro torresHelen bellwoodRegulation services providerCompany second quarterKhiron life sciences corpLife sciencesLatin americaConference callSecond quarterKhiron chief executive officerKhiron chief financial officerChief executive officer

Khiron to Host First Quarter 2022 Conference Call on May 31, 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global medical cannabis leader.

United statesUnited kingdomFranziska katterbachKhiron europeAlvaro torresSwapan kakumanuCompany first quarterRegulation services providerKhiron life sciences corpKhiron life sciencesLatin americaConference callFirst quarterKhiron chief executive officerKhiron chief financial officerChief executive officer

Khiron achieves United Kingdom - GuruFocus com

GuruFocus Article or News written by PRNewswire and the topic is about:

United statesUnited kingdomFranziska katterbachKhiron europeAlvaro torresRegulation services providerKhiron life sciences corpLife sciencesLatin americaEuropean zereniaMedical cannabis clinicsChief executive officerAlthough khironAnnual information formTcpk khrnfTsxv khrn

Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), the global medical cannabis leader.

United statesUnited kingdomFranziska katterbachKhiron europeAlvaro torresRegulation services providerKhiron life sciences corpLife sciencesLatin americaEuropean zereniaMedical cannabis clinicsChief executive officerAlthough khironAnnual information formKhiron life sciences corp

vimarsana © 2020. All Rights Reserved.